News

The Board of Directors proposes decision on a rights issue of units and a directed issue of convertibles

The Board of Directors of Phase Holographic Imaging has today decided to propose that the Extraordinary General Meeting shall decide on a rights issue, which initially can provide the company with approx. SEK 72.4 million.
HoloMonitor fluorescence unit

PHI Introduces Non-invasive Fluorescence

Currently, the HoloMonitor fluorescence unit is being prepared for its first users.
Cell therapy production in a clean-room like environment

Interim Report 2 2021/22

Strong sales growth for the 3rd consecutive quarter. Recent advancements in regenerative medicine create additional growth potential in clinical applications for the company.
Blue cells on white background showing a closing cell gap of a wound healing assay

Interim Report 1 2021/22

The strategic shift of sales and marketing continues to prove itself. Despite being a “slow summer quarter”, sales during May – July surpassed sales during any previous quarter.
Researcher observing instruments at Wake Forest School of Medicine

PHI Enters Regenerative Medicine Partnership

PHI and RegenMed Development Organization have entered a partnership to advance large-scale biomanufacturing of cell-based therapies.
LCI-lp_banner

Year-end Report 2020/21

The strategic shift to focus on digital sales & marketing has been successful, reflected in the sales increase during the latter part of the fiscal year.
Two persons walking in a bright hallway of cell and gene therapy production facility.

Growing Number of Bio-engineering Companies Purchase HoloMonitor

The regenerative medicine company Pandorum Technology recently purchased a complete HoloMonitor system.
Man walking behind glass door next to a Sahlgren Academy poster

Sahlgrenska Acquires Second HoloMonitor System

After an initial purchase by Sahlgrenska University Hospital, Sahlgrenska Center for Cancer Research acquires a second HoloMonitor system.
The HoloMonitor live cell imaging system inside a BioSpherix Xvivo incubator investor relations

BioSpherix Partnership Yields HoloMonitor Customer in Regenerative Medicine

Recently, the EU-funded Centre for Innovative Medicine in Vilnius purchased its first HoloMonitor analyzer for use in the center’s incubator system from BioSpherix.
Massachusetts Eye and Ear Infirmary building

Harvard Researchers Purchase HoloMonitor

Partners HealthCare International in Boston, Massachusetts, recently ordered its first and fully equipped HoloMonitor unit.
1121314151625